Metropolitan Life Insurance CO Syndax Pharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $6,760 - $8,427	343 Added 9.01%	4,150 $98,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $2,976 - $4,462	205 Added 5.69%	3,807 $55,000
Q2 2023 Aug 10, 2023	BUY	$19.35 - $22.31 $6,733 - $7,763	348 Added 10.69%	3,602 $75,000
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $764 - $1,072	-37 Reduced 1.12%	3,254 $68,000
Q4 2022 Jun 14, 2023	BUY	$20.64 - $26.24 $763 - $970	37 Added 1.14%	3,291 $83.8 Million
Q4 2022 Mar 30, 2023	BUY	$20.64 - $26.24 $4,334 - $5,510	210 Added 6.82%	3,291 $83,000
Q4 2022 Feb 15, 2023	BUY	$20.64 - $26.24 $4,334 - $5,510	210 Added 6.82%	3,291 $83,000
Q3 2022 Jun 14, 2023	SELL	$18.51 - $24.79 $3,202 - $4,288	-173 Reduced 5.32%	3,081 $74 Million
Q2 2022 Jun 20, 2023	SELL	$13.64 - $19.48 $2,359 - $3,370	-173 Reduced 5.32%	3,081 $59,000
Q1 2022 Jun 20, 2023	SELL	$14.84 - $22.15 $2,567 - $3,831	-173 Reduced 5.32%	3,081 $53,000
Q1 2022 Mar 30, 2023	SELL	$14.84 - $22.15 $148,043 - $220,968	-9,976 Reduced 76.4%	3,081 $53,000
Q1 2022 May 12, 2022	SELL	$14.84 - $22.15 $148,043 - $220,968	-9,976 Reduced 76.4%	3,081 $54,000
Q4 2021 Jun 21, 2023	BUY	$15.23 - $22.47 $149,299 - $220,273	9,803 Added 301.26%	13,057 $285,000
Q3 2021 Jun 21, 2023	BUY	$13.87 - $19.8 $135,967 - $194,099	9,803 Added 301.26%	13,057 $249,000
Q2 2021 Jun 21, 2023	BUY	$13.42 - $25.18 $131,556 - $246,839	9,803 Added 301.26%	13,057 $224,000
Q2 2021 Mar 30, 2023	BUY	$13.42 - $25.18 $68,804 - $129,097	5,127 Added 64.65%	13,057 $224,000
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $175,117 - $328,573	13,049 Added 163112.5%	13,057 $224,000
Q1 2021 Jun 26, 2023	BUY	$19.28 - $24.59 $90,153 - $114,982	4,676 Added 143.7%	7,930 $177 Million
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $152,736 - $194,801	-7,922 Reduced 99.9%	8 $177,000
Q4 2020 Jun 22, 2023	BUY	$15.1 - $26.44 $70,607 - $123,633	4,676 Added 143.7%	7,930 $176,000
Q3 2020 Jun 26, 2023	BUY	$13.39 - $17.48 $62,611 - $81,736	4,676 Added 143.7%	7,930 $117,000
Q2 2020 Jun 26, 2023	BUY	$8.94 - $20.98 $41,803 - $98,102	4,676 Added 143.7%	7,930 $117,000
Q1 2020 Jul 12, 2023	BUY	$6.65 - $12.03 $31,095 - $56,252	4,676 Added 143.7%	7,930 $86,000
Q1 2020 Mar 30, 2023	BUY	$6.65 - $12.03 $30,849 - $55,807	4,639 Added 140.96%	7,930 $86,000
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $52,734 - $95,397	7,930 New	7,930 $87,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$127 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$94 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$80.2 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$78.6 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$66.1 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account